Comparison of subretinal versus intravitreal injection of recombinant tissue plasminogen activator with gas for submacular hemorrhage secondary to wet age-related macular degeneration: treatment outcomes and brief literature review
International Ophthalmology · 2021-12 · 41 (12) · 4037-4046
DOI: 10.1007/s10792-021-01976-x ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Ophthalmology, online erschienen am 30.07.2021. Verfasst von Paris Tranos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmica Eye Institute, Thessaloniki, Greece. Hauptthemen laut MEDLINE: Retinal Hemorrhage, Tissue Plasminogen Activator, Wet Macular Degeneration. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Contradictory evidence exists over the best approach for the management of submacular hemorrhage (SMH). In this study, we compared the outcomes of subretinal versus intravitreal injection of recombinant tissue plasminogen activator (r-tPA) and gas in cases of SMH secondary to age-related macular degeneration (AMD). METHODS: Twenty five eyes with SMH were retrospectively divided in 2 groups. Group A underwent vitrectomy, subretinal r-tPA and gas (Vitrectomy group, n = 14), and group B received intravitreal r-tPA and gas (Pneumatic group, n = 11). SMH displacement and change in subfoveal hemorrhage thickness (SFHT) at 1 month post-op were assessed. Additionally, best corrected visual acuity (BCVA) and central retinal thickness (CRT) at the end of the 12 month follow-up (FU) were analyzed. Clinical and epidemiological prognostic factors were tested. RESULTS: Mean duration of SMH prior intervention was 8.2(± 7.3) days. Baseline BCVA was 1.53 ± 0.73 LogMAR, mean extension of SMH was 4.604 ± 2079 μm and mean CRT pre-treatment was 795 ± 365 μm. SMH displacement at 1 month post-treatment was total in 9/14 versus 6/11 and partial in 4/14 versus 2/11 in Group A and Group B, respectively (Fisher's exact test p = 0.38). SFHT reduced by 404 ± 312 μm in Group A versus 376 ± 405 μm in group B (p = 0.86). BCVA improvement and reduction of CRT were highly significant at the end of FU (p = 0.002 and p < 0.001 respectively) but did not differ between the 2 groups. Only baseline BCVA and preoperative CRT proved to be significant prognostic factors for the final functional outcome (p = 0.013 and p = 0.047 respectively). CONCLUSION: Both treatment options proved equal efficacy in displacing SMH in AMD. A multicenter trial may delineate a desirable algorithm of treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ophthalmica Eye Institute, Thessaloniki, Greece.
- Swiss Visio Montchoisi, Lausanne, Switzerland.
- Department of Health Sciences, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
- Papageorgiou University Hospital, Thessaloniki, Greece.
- Department of Ophthalmology, School of Medicine, University of Patras, 26504, Rio, Greece. panos.stavrakas@yahoo.com.
Zitieren
APA
Tranos, P., Tsiropoulos, G. N., Koronis, S., Vakalis, A., Asteriadis, S., & Stavrakas, P. (2021). Comparison of subretinal versus intravitreal injection of recombinant tissue plasminogen activator with gas for submacular hemorrhage secondary to wet age-related macular degeneration: treatment outcomes and brief literature review. International Ophthalmology, 41(12), 4037-4046. https://doi.org/10.1007/s10792-021-01976-x
Vancouver
Tranos P, Tsiropoulos GN, Koronis S, Vakalis A, Asteriadis S, Stavrakas P. Comparison of subretinal versus intravitreal injection of recombinant tissue plasminogen activator with gas for submacular hemorrhage secondary to wet age-related macular degeneration: treatment outcomes and brief literature review. International Ophthalmology. 2021;41(12):4037-4046. doi:10.1007/s10792-021-01976-x
BibTeX
@article{Tranos2021,
author = {Tranos, Paris and Tsiropoulos, Georgios N and Koronis, Spyridon and Vakalis, Athanasios and Asteriadis, Solon and Stavrakas, Panagiotis},
title = {Comparison of subretinal versus intravitreal injection of recombinant tissue plasminogen activator with gas for submacular hemorrhage secondary to wet age-related macular degeneration: treatment outcomes and brief literature review},
journal = {International Ophthalmology},
year = {2021},
volume = {41},
number = {12},
pages = {4037--4046},
doi = {10.1007/s10792-021-01976-x}
}
EUVIMED